<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Active Metabolite Pharmacokinetics and Antiplatelet Responses by CYP2C19 Metabolizer Status 
</caption>
<tbody>
<tr>
<th colspan="1"> </th>
<th colspan="1">Dose</th>
<th colspan="1">Ultrarapid<br/>(n=10)</th>
<th colspan="1">Extensive<br/>(n=10)</th>
<th colspan="1">Intermediate<br/>(n=10)</th>
<th colspan="1">Poor<br/>(n=10)</th>
</tr>
<tr>
<td>   C<sub>max</sub> (ng/mL)<br/>
</td>
<td>   300 mg (24 h)<br/>
</td>
<td>24 (10)<br/>
</td>
<td>32 (21)<br/>
</td>
<td>23 (11)<br/>
</td>
<td>11 (4)<br/>
</td>
</tr>
<tr>
<td>   600 mg (24 h)<br/>
</td>
<td>36 (13)<br/>
</td>
<td>44 (27)<br/>
</td>
<td>39 (23)<br/>
</td>
<td>17 (6)<br/>
</td>
</tr>
<tr>
<td>   75 mg (Day 5)<br/>
</td>
<td>12 (6)<br/>
</td>
<td>13 (7)<br/>
</td>
<td>12 (5)<br/>
</td>
<td>4 (1)<br/>
</td>
</tr>
<tr>
<td>   150 mg (Day 5)<br/>
</td>
<td>16 (9)<br/>
</td>
<td>19 (5)<br/>
</td>
<td>18 (7)<br/>
</td>
<td>7 (2)<br/>
</td>
</tr>
<tr>
<td>   IPA (%)*<br/>
</td>
<td>   300 mg (24 h)<br/>
</td>
<td>40 (21)<br/>
</td>
<td>39 (28)<br/>
</td>
<td>37 (21)<br/>
</td>
<td>24 (26)<br/>
</td>
</tr>
<tr>
<td>   600 mg (24 h)<br/>
</td>
<td>51 (28)<br/>
</td>
<td>49 (23)<br/>
</td>
<td>56 (22)<br/>
</td>
<td>32 (25)<br/>
</td>
</tr>
<tr>
<td>   75 mg (Day 5)<br/>
</td>
<td>56 (13)<br/>
</td>
<td>58 (19)<br/>
</td>
<td>60 (18)<br/>
</td>
<td>37 (23)<br/>
</td>
</tr>
<tr>
<td>   150 mg (Day 5)<br/>
</td>
<td>68 (18)<br/>
</td>
<td>73 (9)<br/>
</td>
<td>74 (14)<br/>
</td>
<td>61 (14)<br/>
</td>
</tr>
<tr>
<td>   VASP-PRI (%)<sup>†</sup>
<br/>
</td>
<td>   300 mg (24 h)<br/>
</td>
<td>73 (12)<br/>
</td>
<td>68 (16)<br/>
</td>
<td>78 (12)<br/>
</td>
<td>91 (12)<br/>
</td>
</tr>
<tr>
<td>   600 mg (24 h)<br/>
</td>
<td>51 (20)<br/>
</td>
<td>48 (20)<br/>
</td>
<td>56 (26)<br/>
</td>
<td>85 (14)<br/>
</td>
</tr>
<tr>
<td>   75 mg (Day 5)<br/>
</td>
<td>40 (9)<br/>
</td>
<td>39 (14)<br/>
</td>
<td>50 (16)<br/>
</td>
<td>83 (13)<br/>
</td>
</tr>
<tr>
<td>   150 mg (Day 5)<br/>
</td>
<td>20 (10)<br/>
</td>
<td>24 (10)<br/>
</td>
<td>29 (11)<br/>
</td>
<td>61 (18)<br/>
</td>
</tr>
</tbody>
</table>